Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicita Andreotti

Showing results (111-120 of 236) with videos related to

Pageof 24
Sort By:
American Heart Journal|November 24, 2019
Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million peopleAldo P Maggioni, Letizia Dondi, Felicita Andreotti, et al.
Heart (British Cardiac Society)|January 18, 2007
Relation between nitric oxide metabolites and haemoglobin concentrations in patients with ischaemic heart diseaseFelicita Andreotti, Giulio Coluzzi, Alberto Lavorgna, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 3, 2005
Interplay of platelet polymorphisms, risk factors, and von [corrected] Willebrand factor [corrected] in determining collagen-adenosine diphosphate PFA-100 results in patients with coronary artery diseaseItalo Porto, Antonio Maria Leone, Luisa Nanni, et al.
Heart (British Cardiac Society)|October 16, 2007
IgA anticardiolipin antibody is associated with the extent of daily-life ischaemia in patients with chronic coronary artery diseaseIgnatios Ikonomidis, John Lekakis, Georgia Vamvakou, et al.
Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[Characteristics and clinical use of rivaroxaban for the treatment of atrial fibrillation and venous thromboembolism]Davide Imberti, Giancarlo Agnelli, Felicita Andreotti, et al.
Journal of Thrombosis and Thrombolysis|July 31, 2008
Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasisVincent M G Maher, Yuri Kitano, Clare Neuwirth, et al.
European Journal of Clinical Investigation|April 16, 2011
Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarctionGiampaolo Niccoli, Felicita Andreotti, Francesca Marzo, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2003
Prothrombotic response to coronary angioplasty in patients with unstable angina and raised C-reactive proteinAlessandro Sciahbasi, Felicita Andreotti, Raimondo De Cristofaro, et al.
Giornale Italiano Di Cardiologia (2006)|May 14, 2011
[Double antiaggregant therapy in patients with acute coronary syndrome undergoing coronary angioplasty revascularization. Pending clinical problems and effects of therapy non-compliance]Gianni Casella, Stefano De Servi, Marco Tubaro, et al.
European Heart Journal|May 8, 2010
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Gregory Y H Lip, Kurt Huber, Felicita Andreotti, et al.
Pageof 24

Showing results (111-120 of 236) with videos related to

Sort By:
Pageof 24
American Heart Journal|November 24, 2019
Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million peopleAldo P Maggioni, Letizia Dondi, Felicita Andreotti, et al.
Heart (British Cardiac Society)|January 18, 2007
Relation between nitric oxide metabolites and haemoglobin concentrations in patients with ischaemic heart diseaseFelicita Andreotti, Giulio Coluzzi, Alberto Lavorgna, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 3, 2005
Interplay of platelet polymorphisms, risk factors, and von [corrected] Willebrand factor [corrected] in determining collagen-adenosine diphosphate PFA-100 results in patients with coronary artery diseaseItalo Porto, Antonio Maria Leone, Luisa Nanni, et al.
Heart (British Cardiac Society)|October 16, 2007
IgA anticardiolipin antibody is associated with the extent of daily-life ischaemia in patients with chronic coronary artery diseaseIgnatios Ikonomidis, John Lekakis, Georgia Vamvakou, et al.
Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[Characteristics and clinical use of rivaroxaban for the treatment of atrial fibrillation and venous thromboembolism]Davide Imberti, Giancarlo Agnelli, Felicita Andreotti, et al.
Journal of Thrombosis and Thrombolysis|July 31, 2008
Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasisVincent M G Maher, Yuri Kitano, Clare Neuwirth, et al.
European Journal of Clinical Investigation|April 16, 2011
Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarctionGiampaolo Niccoli, Felicita Andreotti, Francesca Marzo, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2003
Prothrombotic response to coronary angioplasty in patients with unstable angina and raised C-reactive proteinAlessandro Sciahbasi, Felicita Andreotti, Raimondo De Cristofaro, et al.
Giornale Italiano Di Cardiologia (2006)|May 14, 2011
[Double antiaggregant therapy in patients with acute coronary syndrome undergoing coronary angioplasty revascularization. Pending clinical problems and effects of therapy non-compliance]Gianni Casella, Stefano De Servi, Marco Tubaro, et al.
European Heart Journal|May 8, 2010
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Gregory Y H Lip, Kurt Huber, Felicita Andreotti, et al.
Pageof 24